Université Clermont Auvergne, INRA, UNH, Unité de Nutrition Humaine, Laboratoire d'Immunologie, Clermont-Ferrand, France
Université Clermont Auvergne, UMR CNRS 6023 LMGE, Laboratoire de Bactériologie, Clermont-Ferrand, France.
Infect Immun. 2019 Oct 18;87(11). doi: 10.1128/IAI.00570-19. Print 2019 Nov.
Some respiratory infections have been associated with dysbiosis of the intestinal microbiota. The underlying mechanism is incompletely understood, but cross talk between the intestinal microbiota and local immune cells could influence the immune response at distal mucosal sites. This has led to the concept of enhancing respiratory defenses by modulating the intestinal microbiota with exogenous supplementation of beneficial strains. In this study, we examined the effect of CIRM653 on the inflammatory response induced by the pathogen Oral administration of CIRM653 to mice subsequently infected by via the nasal route (i) reduced the pulmonary inflammation response, with decreased numbers of lung innate immune cells (macrophages and neutrophils) and cytokines (mouse keratinocyte-derived chemokine [KC], interleukin-6 [IL-6], and tumor necrosis factor alpha [TNF-α]) in the bronchoalveolar fluid, and (ii) induced an immunosuppressive Treg response in lungs. coincubation of CIRM653 and with human dendritic cells and peripheral blood mononuclear cells resulted in decreased Th1 (IL-12p70 and interferon gamma [IFN-γ]) and Th17 (IL-23 and IL-17) and increased Treg (IL-10) cytokine levels compared to those observed for -infected cells. Neither nor CIRM653 had any effect on cytokine production by intestinal epithelial cells , but the induction of the NF-κB pathway and IL-8 and IL-6 production by in airway epithelial cells was significantly reduced when the pathogen was coincubated with CIRM653. The remote IL-10-mediated modulation of the inflammatory response by CIRM653 supports the concept of immunomodulation by beneficial bacteria through the gut-lung axis.
一些呼吸道感染与肠道微生物群落的失调有关。其潜在机制尚未完全阐明,但肠道微生物群落与局部免疫细胞之间的相互作用可能会影响远端黏膜部位的免疫反应。这导致了通过用有益菌株外源性补充来调节肠道微生物群落从而增强呼吸道防御的概念。在这项研究中,我们研究了 CIRM653 对病原体诱导的炎症反应的影响。通过鼻腔途径感染后,经口给予 CIRM653 (i)减少了肺部炎症反应,肺固有免疫细胞(巨噬细胞和中性粒细胞)和细胞因子(鼠角质细胞衍生趋化因子[KC]、白细胞介素-6[IL-6]和肿瘤坏死因子α[TNF-α])在支气管肺泡液中的数量减少,(ii)诱导肺部免疫抑制性 Treg 反应。CIRM653 与人类树突状细胞和外周血单核细胞共培养后,与感染细胞相比,Th1(IL-12p70 和干扰素γ[IFN-γ])和 Th17(IL-23 和 IL-17)细胞因子水平降低,而 Treg(IL-10)细胞因子水平升高。CIRM653 对肠道上皮细胞细胞因子产生均无影响,但当病原体与 CIRM653 共培养时,气道上皮细胞中 NF-κB 途径和 IL-8 和 IL-6 的产生明显减少。CIRM653 通过远程 IL-10 调节引起的对 的炎症反应的调节支持有益细菌通过肠道-肺轴进行免疫调节的概念。